https://www.selleckchem.com/products/gw6471.html
To explore the safety and clinical utility of MRI in participants with non-MRI-conditional cardiac implantable electronic devices, by establishing the Patient Registry of Magnetic Resonance Imaging in Non-Approved DEvices (PROMeNADe). From September 2015 to June 2019, 532 participants (211 women) with a mean age of 69 years ± 14 (standard deviation) were enrolled prospectively in the PROMeNADe registry (ClinicalTrials.gov identifier NCT03081364) and underwent a total of 608 MRI examinations (61 cardiac MRI examinations). All participants
Gefällt mir
Kommentar
Teilen
